RxDoctor Payments Data

Joshua Parker, MD

Clinical Cardiac Electrophysiology · Greensboro, NCNPI 1568824175

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (37.5%), food and beverage and grants — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Boston Scientific at 53.5% of the total. Reporting peaked in 2023 at $10,118 and has fallen 80.1% since, to $2,015 in 2025.

$19,038in general payments, 2019–2025

Across 134 payments — averaging $142.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$10K
  • Medtronic$6K
  • Abbott$2K
  • Biotronik Inc.$689
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$204
  • Biosense Webster, Inc.$170
  • plus $353 from 8 others
$9,342in research payments, 2019–2025

Across 50 payments — averaging $186.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$9K

What the payments were for

  • Grants$5,00026%
  • Travel & lodging$7,13637%
  • Food & beverage$6,08832%
  • Education$8154%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,038 in reported general payments places this provider in the 55th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.

See all clinical cardiac electrophysiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$17,630
Medicare patients
76
Services billed
158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban15$16,181
Metoprolol Succinate21$394
Amiodarone Hcl16$208

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →